Literature DB >> 30517920

Body Fluids in End-Stage Renal Disease: Statics and Dynamics.

Jeroen P Kooman1, Frank M van der Sande2.   

Abstract

BACKGROUND: Abnormalities in fluid status in hemodialysis (HD) patients are highly prevalent and are related to adverse outcomes.
SUMMARY: The inherent discontinuity of the HD procedure in combination with an often compromised cardiovascular response is a major contributor to this phenomenon. In addition, systemic inflammation and endothelial dysfunction are related to extracellular fluid overload (FO). Underlying this relation may be factors such as hypoalbuminemia and an increased capillary permeability, leading to an altered fluid distribution between the blood volume (BV) and the interstitial fluid compartments, compromising fluid removal during dialysis. Indeed, whereas estimates of extracellular volume by bioimpedance spectroscopy are highly predictive of mortality, absolute BV assessed by the saline dilution technique was predictive of intra-dialytic morbidity. Changes in relative BV during HD are positively related to ultrafiltration rate (UFR) and, at least in some studies, negatively to FO. High UFR is also related to changes in central venous oxygen saturation (ScvO2), a marker for tissue perfusion. On the one hand, high UFR and more pronounced declines in ScvO2, but on the other hand, flat relative BV curves are also predictive of mortality; the relation between outcome which statics and dynamics of fluid status appears to be complex. Key Message: While technological developments enable the clinician to monitor statics and dynamics of fluid status and hemodynamics during HD in an accessible way, the role of technology-based interventions needs further study.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Absolute blood volume; Bioimpedance spectroscopy; Fluid overload; Hemodialysis; Oxygen saturation; Relative blood volume

Mesh:

Year:  2018        PMID: 30517920      PMCID: PMC6492508          DOI: 10.1159/000494583

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  70 in total

1.  Clinical use of continuous blood volume monitoring.

Authors:  F Lopot
Journal:  EDTNA ERCA J       Date:  1996 Oct-Dec

2.  Strong association between volume status and nutritional status in peritoneal dialysis patients.

Authors:  Li-Tao Cheng; Wen Tang; Tao Wang
Journal:  Am J Kidney Dis       Date:  2005-05       Impact factor: 8.860

3.  Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial.

Authors:  Donal N Reddan; Lynda Anne Szczech; Vic Hasselblad; Edmund G Lowrie; Robert M Lindsay; Jonathan Himmelfarb; Robert D Toto; John Stivelman; James F Winchester; Linda A Zillman; Robert M Califf; William F Owen
Journal:  J Am Soc Nephrol       Date:  2005-06-01       Impact factor: 10.121

4.  A whole-body model to distinguish excess fluid from the hydration of major body tissues.

Authors:  Paul W Chamney; Peter Wabel; Ulrich M Moissl; Manfred J Müller; Anja Bosy-Westphal; Oliver Korth; Nigel J Fuller
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

5.  Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes.

Authors:  Max Nieuwdorp; Hans L Mooij; Jojanneke Kroon; Bektas Atasever; Jos A E Spaan; Can Ince; Frits Holleman; Michaela Diamant; Robert J Heine; Joost B L Hoekstra; John J P Kastelein; Erik S G Stroes; Hans Vink
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

6.  Fluid state and blood pressure control in patients treated with long and short haemodialysis.

Authors:  K S Katzarski; B Charra; A J Luik; J Nisell; J C Divino Filho; J K Leypoldt; K M Leunissen; G Laurent; J Bergström
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

7.  Long 3 x 8 hr dialysis: a three-decade summary.

Authors:  Bernard Charra; Charles Chazot; Guillaume Jean; Jean-Marc Hurot; Thierry Vanel; Jean-Claude Terrat; Cyril VoVan
Journal:  J Nephrol       Date:  2003 Nov-Dec       Impact factor: 3.902

8.  Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume?

Authors:  Claudia Barth; Walter Boer; Daniela Garzoni; Thomas Kuenzi; Wolfgang Ries; Ralf Schaefer; Daniel Schneditz; Theoharis Tsobanelis; Frank van der Sande; Ralf Wojke; Holger Schilling; Jutta Passlick-Deetjen
Journal:  Nephrol Dial Transplant       Date:  2003-07       Impact factor: 5.992

9.  Relative plasma volume monitoring during hemodialysis AIDS the assessment of dry weight.

Authors:  Arjun D Sinha; Robert P Light; Rajiv Agarwal
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

10.  The mortality risk of overhydration in haemodialysis patients.

Authors:  Volker Wizemann; Peter Wabel; Paul Chamney; Wojciech Zaluska; Ulrich Moissl; Christiane Rode; Teresa Malecka-Masalska; Daniele Marcelli
Journal:  Nephrol Dial Transplant       Date:  2009-01-07       Impact factor: 5.992

View more
  4 in total

Review 1.  Intradialytic Hypotension: Mechanisms and Outcome.

Authors:  Benedict Sars; Frank M van der Sande; Jeroen P Kooman
Journal:  Blood Purif       Date:  2019-12-18       Impact factor: 2.614

2.  Postoperative outcomes of cancer surgery in patients with and without kidney failure with dialysis therapy: a matched-pair cohort study.

Authors:  Yoshihisa Miyamoto; Masao Iwagami; Shotaro Aso; Kazuaki Uda; Kiyohide Fushimi; Yoshifumi Hamasaki; Masaomi Nangaku; Hideo Yasunaga; Kent Doi
Journal:  Clin Kidney J       Date:  2022-01-13

3.  The Prevalence and Independent Risk Factors of Significant Tricuspid Regurgitation Jets in Maintenance Hemodialysis Patients With ESRD.

Authors:  Ying Zhang; Xiao-Han Ding; Fang Pang; Laiping Zhang; Yiqin Wang; Weili Wang; Rongsheng Rao; Shi-Zhu Bian
Journal:  Front Physiol       Date:  2020-12-17       Impact factor: 4.566

Review 4.  Clinical relevance of abstruse transport phenomena in haemodialysis.

Authors:  Sudhir K Bowry; Fatih Kircelli; Mooppil Nandakumar; Tushar J Vachharajani
Journal:  Clin Kidney J       Date:  2021-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.